From Skepticism to Support: Healthcare Providers’ Acceptance of Digital Interventions in Su...
Introduction
Substance use disorders (SUDs) present a significant global and local health concern. According to the World Drug Report 5.8% of the population aged 15-64 in the year 2021, equivalent to 296 million indi...
Modernising AI Medical Devices Regulation: FDA’s Firm-Based Approach
Introduction
The regulation of artificial intelligence (AI) medical devices has become a pressing issue. The US Food and Drug Administration (FDA) has adopted a firm-based approach for regulating lower-risk m...
Abu Dhabi Strategic Healthcare Partnerships: Global Collaborations
Introduction
Abu Dhabi is making substantial progress in healthcare innovation through strategic partnerships with leading global institutions. The Department of Health – Abu Dhabi (DoH) ha...
Genome-Wide Sequencing in Diagnosing Rare Diseases: Clinical and Economic Implications
Introduction
Genome-wide sequencing (GWS) has emerged as a crucial diagnostic tool in the identification of rare diseases. This technique, which includes whole-exome sequencing (WES) and whol...
Antenatal HCV Screening in Egypt: Paving the Path to Elimination
Introduction to Hepatitis C in Egypt
Globally, 58 million people live with chronic hepatitis C virus (HCV) infection. Although no vaccine exists, affordable, safe, and highly effective short-course treatments with direct acting antivirals (DAA...
